SMTL ID : 8jyq.1 (1 other biounit)

Crystal structure of cancer-specific anti-HER2 antibody H2Mab-214 in complex with epitope peptide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

hetero-1-1-mer

Ligands

1 x MET- PRO- ILE- TRP- LYS- PHE- PRO- ASP: H2CasMab-1 epitope peptide(Non-covalent)

MET-PRO-ILE-TRP-LYS-PHE-PRO-ASP.1: 19 residues within 4Å: Chain A: S.34, G.35, H.54, F.56, W.57, D.58, D.60, R.62, R.102, V.104, A.105, T.106, W.108 Chain B: Y.33, L.38, S.97, R.98, V.100, L.102 24 PLIP interactions: 15 interactions with chain A, 9 interactions with chain B Hydrophobic interactions: A:H.54, A:F.56, A:F.56, A:W.57, A:R.62, A:V.104, A:V.104, A:W.108, B:Y.33, B:Y.33, B:L.38, B:V.100, B:L.102 Hydrogen bonds: A:D.58, A:D.60, A:R.102, A:R.102, A:A.105, B:Y.33, B:Y.33, B:Y.33, B:Y.33 Water bridges: A:R.62, A:R.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Arimori, T. et al., Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies. Structure (2024)

Release Date

2024-03-13

Peptides

H2CasMab-1 VH(S112C),SARAH: A
H2CasMab-1 VL,SARAH(S37C): B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

H2CasMab-1 VH(S112C),SARAH

H2CasMab-1 VL,SARAH(S37C)

Related Entries With Identical Sequence